0001104659-16-139358.txt : 20160812
0001104659-16-139358.hdr.sgml : 20160812
20160812163054
ACCESSION NUMBER: 0001104659-16-139358
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160811
FILED AS OF DATE: 20160812
DATE AS OF CHANGE: 20160812
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptimmune Therapeutics PLC
CENTRAL INDEX KEY: 0001621227
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 101 PARK DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RY
BUSINESS PHONE: 44 1235 430000
MAIL ADDRESS:
STREET 1: 101 PARK DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON, OXFORDSHIRE
STATE: X0
ZIP: OX14 4RY
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptimmune Ltd
DATE OF NAME CHANGE: 20141001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sigal Charles Elliott
CENTRAL INDEX KEY: 0001661908
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37368
FILM NUMBER: 161828630
MAIL ADDRESS:
STREET 1: 32 BREARLY ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
a4.xml
4
X0306
4
2016-08-11
0
0001621227
Adaptimmune Therapeutics PLC
ADAP
0001661908
Sigal Charles Elliott
32 BREARLY ROAD
PRINCETON
NJ
08540
1
0
0
0
Option to purchase Ordinary Shares
1.27
2016-08-11
4
A
0
184562
0
A
2017-08-11
2026-08-11
Ordinary Shares
184562
184562
D
The exercise price was converted from GBP0.97 based on the closing midpoint exchange rate for the U.S. dollar on the day prior to the date of grant listed in the Financial Times. The actual exercise price will be the pounds sterling amount.
/s/ Charles Elliott Sigal
2016-08-12